LONDON, ENGLAND / ACCESSWIRE / May 21, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together “Bio-AMD,” “We” or the “Company” OTCQB: BIAD) is pleased to announce that it is to formalise implementation of the International Organisation for Standardization quality standards ISO 9001:2008 and ISO 13485:2012.

The Company, which already works to the requirements of these standards, has engaged a specialist ISO quality standard consultancy to provide support for this implementation as we move through our technology commercialization process.

ISO 9001 is the world’s most popular quality management system framework. More than a million organisations in over 175 countries are certified to its requirements. The standard’s focus is on the use of planning to drive success through improved customer satisfaction, motivation of personnel and continual improvement.

ISO 13485 is the preferred management system for the quality control of medical devices. The standard “tunes” the fundamental requirements of ISO 9001 to provide a management framework for the design and production of medical devices and in-vitro diagnostic devices. ISO 13485 is an essential requirement for the mandatory CE conformity marking of medical devices manufactured in or designed to be sold in the European Economic Area.

Registration of devices to both the above standards will also provide a robust platform from which to apply for regulatory approval for the Company’s technologies in non-European markets, such as from the U.S. Food and Drug Administration.

Dr Djennati, Managing Director of Bio Alternative Medical Devices Ltd., said, “ISO 9001 and ISO 13485 are the primary international quality standards applicable to med-tech companies. Registration will provide our partners and customers assurance that our products have been through a rigorous quality process that will continue well beyond a product launch. We are confident that we will achieve registration to both ISO standards, which will further enhance our reputation in the healthcare sector.”

About Bio-AMD, Inc.:

Bio-AMD has two majority owned UK subsidiaries: Bio-AMD Limited, a technology developer for medical diagnostic devices; and WOCU Ltd, the owner of the WOCU(R), a global currency data reference source for application in financial markets. (www.wocu.com).

To find out more about Bio-AMD (OTCQB: BIAD), visit our website at www.bioamd.com.

Forward-Looking Statements:

Statements in this news release that are not statements of historical fact are forward-looking statements, which are subject to certain risks and uncertainties. Forward-looking statements can often be identified by words such as “expects,” “intends,” “plans,” “may,” “could,” “should,” “anticipates,” “likely,” “believes” and words of similar import. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of factors that may or may not be foreseeable or within the reasonable control of the Company. Readers are cautioned not to place undue reliance on such forward-looking statements. Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the U.S. Securities and Exchange Commission, including without limitation the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 filed on March 30, 2015, and in Company reports filed subsequently thereto. Except as otherwise required by law, the Company disclaims any obligations or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this news release to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

CONTACT:
Bio-AMD, Inc.
Tom Barr, CEO
+44 (0)8445 861 910

SOURCE: Bio-AMD, Inc.

ReleaseID: 429125

CUPERTINO, CA / ACCESSWIRE / May 21, 2015 / Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced that Eric McAfee, Chairman and CEO, is scheduled to present at the upcoming Marcum Microcap Conference on Thursday, May 28, 2015. The 2015 Marcum Microcap Conference will be held in New York City at the Grand Hyatt Hotel.

Aemetis’ presentation is scheduled to begin at 10:00 a.m. ET. For additional information about Aemetis, or to view the company’s corporate presentation, please visit http://www.aemetis.com.

The annual Marcum MicroCap Conference is a showcase for public companies with less than $500 million in market capitalization. For more information or to register, please visit the conference website at http://www.marcumllp.com/microcap.

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

About the Marcum MicroCap Conference

The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies under $500 million in market capitalization can network with the investment community. The conference features presentations by CEOs and CFOs from six principal industry sectors and provides investors with the opportunity to meet with management of these companies on a one-on-one basis. Industry sectors include Technology, Media & Internet; Software & Business Services; Life Science & Healthcare; Retail & Consumer Products; Energy & Natural Resources; and Industrials. The conference additionally includes a full agenda of panel discussions on issues of strategic importance to small cap issuers and investors, moderated by industry leaders.

The Marcum MicroCap Conference attracts fund managers and high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace. For complete information about the 2015 Marcum MicroCap Conference, visit www.marcumllp.com/microcap.

Marcum is a registered Public Company Accounting Oversight Board (PCAOB) firm. Marcum’s Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. Marcum’s SEC Practice led the audit industry in most net new public company clients in the fourth quarter of 2013. For more information, visit www.marcumllp.com.

About Marcum LLP

Marcum LLP is one of the largest independent public accounting and advisory services firms in the United States. Ranked #15 nationally, Marcum LLP offers the resources of 1,300 professionals, including over 160 partners, in 23 offices throughout the U.S., Grand Cayman and China. Headquartered in New York City, the Firm’s presence runs deep, with full-service offices strategically located in major business markets. Marcum is a member of the Marcum Group, an organization providing a comprehensive range of professional services spanning accounting and advisory, technology solutions, wealth management, and executive and professional recruiting. The Marcum Group companies include Marcum LLP; Marcum Technology LLC; Marcum Search LLC; Marcum Financial Services LLC; Marcum Bernstein & Pinchuk LLP; and MarcumBuchanan Associates LLC.

Investor Relations:

Michael Bayes
(415) 389-4670
michaelbayes@liviakis.com

Company Contact:

Satya Chillara
(408) 213-0939
schillara@aemetis.com

Media Contact:

Melanie Borchardt
(408) 213-0938
mborchardt@aemetis.com

SOURCE: Aemetis, Inc.

ReleaseID: 429108

EDMONDS, WA / ACCESSWIRE / May 21, 2015 / American Brewing Company, Inc.(R), (PINKSHEETS:ABRW) (“ABC”), an award-winning micro-brewing company and owner of bucha(TM) live Kombucha, today released the following letter to its shareholders.

Dear Shareholders,

I wanted to take this opportunity to update you on what is transpiring at our Company, notably regarding the acquisition of the bucha(TM) live Kombucha brand from B&R Liquid Adventures, LLC.

As many of you know, the Company has been transformed into a full beverage company. The natural/organic foods industry is one of the fastest growing beverage segments. Our goal is to become an established brand in this industry, with a footprint in the majority of the states. We now have the opportunity to capitalize on the established business that bucha(TM) has created over the years using our proprietary processes and great flavors. With solid double digit growth in the present and also anticipated in the future, we are excited about the prospects.

We believe that ABC is differentiated from other Kombucha tea providers, as the flavor profile of our drink is purposed for mainstream audiences. We believe that we are making a delicious beverage with the same health benefits commonly associated with Kombucha tea. In addition, we believe we have significant competitive advantages with our newly formed and experienced management team. Our new COO, Chuck Santry, comes from the food industry, where he started with Santa Barbara Salsa Company (revenue about $800K/yr). Santa Barbara sold to California Creative Foods (at about $4M/yr), which eventually sold to a JV of Pepsico and the Strauss Group (at about $44M/yr). Chuck in that position was able to establish large national distribution networks, as well as an assortment of different private label deals. Our goal is to leverage Chuck’s pre-existing relationships and grow the bucha brand in this same fashion.

Given the large size of the Kombucha purchase, many of you have expressed an interest in seeing actual sales & profit numbers. Rest assured that this information will be released upon the anticipated completion of the audited financials around the middle of June. Included in the release will be the 2014 sales and P/L information as well as the change (in terms of dollars and percent) from 2013, and forward guidance based on our first few months of sales within the ABRW umbrella.

When reviewing these numbers please note that they 1) include large non-recurring legal fees which will not be applied in the future and 2) inefficiencies of prior management. Neither of those is applicable in the present or future now that we own the brand, so there should be significant immediate bottom line improvement to be recognized by us. We have applied new cost structures and our goal is to not only grow the business, but to show profitability from operations.

On a related note, both myself and Julie Anderson (the Company’s Vice President) forgave $500,000 of the $600,000 in accrued compensation we were owed. This was done after much deliberation as our way of showing our fellow shareholders our dedication to the Company.

Currently a force in the natural segment, we desire to expand our sparkling Kombucha tea into the mainstream market. We hope to achieve that by recruiting a well-recognized spokesperson and introducing our products into traditional stores and large box retailers. We have already made significant footprints in Kroger (per sales data we are the #2 selling brand), Safeway and Whole Foods just to name a few.

Another growth avenue we are exploring is introducing our product in a private label format. The effect of this is to broaden the consumer awareness of kombucha.

Finally, I would like to discuss our $500,000 secondary stock offering we filed in April. These funds are to be used for future accretive acquisitions, general corporate needs and to possibly repay some of the approximately $400,000 of promissory notes we incurred related to the purchase of bucha. None of this money was needed for day to day operations. I said it in my last shareholder letter and it is worth mentioning again.

There is no doubt that American Brewing has accomplished a great deal this year. I am very proud of all of the people that have worked so hard to get us here. I remain excited about the possibilities that are before us. And of course I want to thank you for the trust and confidence that you’ve placed in our company.

We anticipate having many more updates in the future. Until then, I and the rest of the American Brewing family wish you best of health and prosperity.

About American Brewing Company(R)

Founded in 2010, American Brewing Company, Inc.(R), is an award-winning micro-brewing company based out of Edmonds, Washington. American Brewing Company’s(R) current offerings include Breakaway IPA (named ‘Best in the West’ by Beer West Magazine), American Blonde (featured in GQ Magazine), Flying Monkey Dogfight Pale Ale, and Caboose Oatmeal Stout. American Brewing Company(R) also owns bucha live Kombucha which features 8 flavors of its sparkling kombucha tea. For more information, please visit: http://www.americanbrewing.com/. And http://www.mybucha.com/ .

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. These statements include, without limitation, predictions and guidance relating to the company’s future financial performance and the research, development and commercialization of its technologies. In some cases, you can identify forward-looking statements by terminology such as, “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. These forward-looking statements are based on management’s current expectations, but they involve a number of risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements, as the result of such factors, risks and uncertainties as (1) competition in the markets for the products and services sold by the company, (2) the ability of the company to execute its plans, (3) other factors detailed in the company’s public filings with the SEC, which are available at http://www.sec.gov/. You are urged to consider these factors carefully in evaluating the forward-looking statements.

Contacts

Corporate:

Neil Fallon, CEO
American Brewing Company(R)
Email: neil@americanbrewing.com

SOURCE: American Brewing Company, Inc.(R)

ReleaseID: 429107

SUNNYVALE, CA / ACCESSWIRE / May 21, 2015 / Viveve Medical, Inc. (“Viveve”) (OTCQB: VIVMF), a company focused on women’s health, today announced that Patricia Scheller, CEO and Scott Durbin, CFO will present at the SeeThru Equity 4th Annual Microcap Investor Conference at the Convene Grand Central in Midtown Manhattan, New York, on Thursday, May 28th.

Ms. Scheller and Mr. Durbin will provide an overview of the Company’s business and products, details of its commercial efforts and updates on newly signed partnerships at the event. The Company’s recorded presentation, including audio, will be available immediately following the meeting at: http://wsw.com/webcast/seethru11/vivmf.

Members of the investment community interested in meeting with management that day can contact their representative at SeeThru Equity, or Amato and Partners.

“We are pleased to be participating in one of the premier annual microcap investor conferences,” said Patricia Scheller, Chief Executive Officer, “We look forward to interacting with as many of the over 600 attendees as possible during the meeting, and sharing the Viveve story with them.”

About Viveve

Viveve, Inc., the operating subsidiary of Viveve Medical, Inc., is a women’s health company passionately committed to advancing new solutions to improve women’s overall well-being and quality of life. The company’s lead product, the globally patented Viveve(R) System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue with only one treatment session. The Viveve System treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth that can result in a decrease in physical sensation and sexual satisfaction. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontinence or stretch marks. The Viveve Treatment uses patented, reverse-thermal gradient radiofrequency technology to tighten vaginal tissue in one 30-minute out-patient treatment in a physician’s office. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. It is currently not available for sale in the U.S. For more information, please visit Viveve’s website at www.viveve.com.

Safe Harbor Statement

All statements in this press release that are not based on historical fact are “forward-looking statements.” While management has based any forward-looking statements included in this press release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are to be detailed in our periodic and current reports available for review at www.sec.gov. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Viveve is a registered trademark of Viveve, Inc.

Contact:

Amato and Partners, LLC
Investor Relations Counsel
90 Park Avenue. 17th Floor
New York, NY 10016
212.430.0360
admin@amatoandpartners.com

SOURCE: Viveve Medical, Inc.

ReleaseID: 429111

HOUSTON, TX / ACCESSWIRE / May 21, 2015 / On May 19, 2015, SCT&E LNG signed a Memorandum of Understanding (MOU) with a sizable U.S. upstream natural gas supplier for its world-scale liquefied natural gas (LNG) project on Monkey Island, Cameron Parish, Louisiana. The agreement provides enough natural gas to enable the company to produce 4 million tons per annum (mtpa) of LNG. The agreement represents one third of the gas needed for the entire project (12 mtpa) with terms that allow for additional supply.

SCT&E LNG currently has approval from the Department of Energy to export 12 mtpa to countries with whom the U.S. has a Free Trade Agreement. Greg Michaels, Chairman and CEO of SCT&E LNG, states, “During our recent 45-day trip to Asia and South America meeting with potential investors and offtakers, we received extremely positive feedback on the potential for a long-term fixed-price natural gas supply. A number of prospective customers consider our offering as a hedge against future unknown gas prices. The MOU provides our customers with a fixed-price commercial structure they can bank on to build their economies and deploy 20-plus year assets with measureable and predictable results. This agreement represents another significant milestone in our project.”

The SCT&E LNG business model seeks to export LNG via take-or-pay tolling arrangements with its customers. Mr. Michaels continues, “Our business model has been designed to provide our shareholders with the potential for maximum return while limiting exposure on their investment. To date, all project activities have been self-financed, which include a signed long-term lease option for our project site, multiple project feasibility studies, key staff hires, the opening of our corporate headquarters in Houston, Texas, and the secured feedstock for 4 mtpa of our authorized 12 mtpa project. To be at this stage of a $9 plus billion dollar project with zero debt is something our team is very proud of.”

About SCT&E LNG:

Originally established by Southern California Telephone Company, doing business as Southern California Telephone & Energy (SCT&E), SCT&E LNG, INC. is a Nevada Corporation and a developer of an LNG export terminal. The SCT&E LNG project is currently modeled as an LNG tolling facility utilizing cryogenic technologies to liquefy natural gas for the exportation of natural gas globally. The SCT&E LNG plan is to liquefy approximately 1.62 billion cubic feet per day of natural gas to create approximately 12 million tons per annum of LNG at its future facilities on Monkey Island, Cameron Parish, Louisiana.

Southern California Telephone Company, today SCT&E, is a successful twenty-year, privately owned United States Public Utility Company. The company was originally founded in 1994 as Wholesale Airtime, Inc. by CEO Greg Michaels. SCT&E is a telecommunications and energy company. SCT&E owns and operates a redundant telecommunications network and maintains facilities on both coasts of the United States. SCT&E holds a U.S. Federal Energy Regulatory Commission (FERC) Authority allowing it to buy and sell energy nationwide. SCT&E LNG has multiple locations, with its corporate office headquartered in Temecula California.

Safe Harbor:

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks, uncertainties, and assumptions that include expected earnings, future growth and financial performance, and typically can be identified by the use of words such as “expect,” “estimate,” “anticipate,” “forecast,” “plan,” “believe,” “optimistic,” “intend,” “will,” and similar terms. Although SCT&E LNG believes that its expectations are reasonable, it can give no assurance that these expectations will prove to have been correct, and actual results may vary materially from those anticipated in these forward-looking statements. A variety of factors that could cause actual results to differ materially from those contemplated above include, among others, general economic conditions, hazards customary in the oil, gas and LNG industries, weather conditions, competition and developments in oil, gas and LNG markets beyond the Company’s control, the volatility of energy and fuel prices, failure of customers to perform under contracts, changes in the oil, gas and LNG markets, changes in government regulations of markets and of environmental emissions, the condition of capital markets generally, securitization of sufficient capital or a strategic business arrangement to fund its plan of operation, the Company’s ability to access capital markets, management resources and infrastructure necessary to support the growth of its business, unanticipated facilities outages, adverse results in current and future litigation, failure to identify or successfully implement acquisitions (including receipt of third party consents and regulatory approvals), failure to acquire or transact on off-take agreements, and other risk factors related to the liquefied natural gas and related and connected business.

All forward-looking statements attributable to SCT&E LNG or persons acting on its behalf are expressly qualified in their entirety by these factors. SCT&E LNG undertakes no obligation to update or revise any forward-looking statements, other than as required under applicable securities laws, whether as a result of new information, future events or otherwise. The foregoing factors could cause SCT&E LNG’s actual results to differ materially from those contemplated in the forward-looking statements included in this news release and should be considered in connection with information regarding risks and uncertainties that may affect SCT&E LNG’s future results.

CONTACT:

Lisa Musick, Public Relations
SCT&E LNG, INC.
15021 Katy Freeway, Suite 210
Houston, Texas 77094
lisa.m@sctelng.com
www.sctelng.com

SOURCE: SCT&E LNG

ReleaseID: 429123